At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 32 enrolled
Drug / intervention
Tretinoin cream 0.005% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Clinical Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Recent Stretch Marks
In Brief
A Phase 4 clinical trial evaluating Tretinoin cream 0.005% and Superficial Dermabrasion for Stretch Marks and 2 related conditions. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This study aims to evaluate head-to-head the effectiveness of tretinoin 0.5% and superficial dermabrasion in subjects that have recent stretch marks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStretch Marks, Striae, Treatment
CountriesBrazil
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedDec 2009
Primary CompletionAug 2010
TodayJul 2026
First PostedDec 9, 2009
Enrollment StartMar 1, 2009
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.6 years ago
Interventions
Tretinoin cream 0.005%drug
Group 1 will receive tretinoin cream 0.05%(Vitanol A, Stiefel) that should be applied daily in areas affected by stretch marks, in both sides, for a period of 16 weeks.
Superficial Dermabrasiondevice
Group 2 will receive 16 sessions of dermabrasion that would be held in the research center